Clinical Trial Update: Effect of Cerefolin®/CerefolinNAC® on Biomarker Measurements

View source ↗

Summary

Completed clinical trial evaluating Cerefolin and CerefolinNAC on biomarker measurements in people with mild cognitive impairment and Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Cerefolin
• CerefolinNAC

Snippet

Sponsor: Pamlab, Inc. | Conditions: Mild Cognitive Impairment, Alzheimer's Disease | Status: COMPLETED